Skip to main content
Clinical Trials/JPRN-UMIN000012025
JPRN-UMIN000012025
Completed
Phase 2

Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancer - Phase 2 study of CBDCA and weekly nab-PTX for elderly squamous cell lung cancer

Osaka City General Hospital0 sites35 target enrollmentOctober 11, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
squamous cell lung cancer
Sponsor
Osaka City General Hospital
Enrollment
35
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2013
End Date
August 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)With active other organ cancer 2\)With active infection 3\)With fever equal to or more than 38C 4\)With mental disorder 5\)With symptomatic brain metastasis 6\)Pleural and peritoneal effusion likely to require surgical intervention,or pericardial effusion 7\) Systematic steroids , immunosuppressive medication or poorly controlled diabetes 8\)Grade 2 or higher peripheral neuropathy 9\)Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 10\)poorly controlled hypertension 11\)Ischemic heart disease or cardiac infarction within 6 months before enrollment 12\)History of severe drug allergies 13\)Physician concludes that the patient's participation in this trial is inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials